Patents by Inventor Cornelia Bentley

Cornelia Bentley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VECTORS AND METHODS FOR IN VIVO TRANSDUCTION
    Publication number: 20230304031
    Abstract: The disclosure provides compositions and methods for inducing an immunity via cellular expression of an antigen receptor binding construct in vivo.
    Type: Application
    Filed: May 11, 2021
    Publication date: September 28, 2023
    Inventors: Douglas J. Jolly, Derek G. Ostertag, Noriyuki Kasahara, Carlos Ibanez, Cornelia A. Bentley, Mohd Mushtaq Husain
  • CAR T CELL METHODS AND CONSTRUCTS
    Publication number: 20220090132
    Abstract: The disclosure provides non-replicating viral vectors (RNV) for adoptive cell therapy. The RNVs can deliver chimeric antigen receptors to immune cells (e.g., T-Cells) in vivo.
    Type: Application
    Filed: January 6, 2020
    Publication date: March 24, 2022
    Inventors: Douglas J. Jolly, Joan M. Robbins, Amy H. Lin, Derek G. Ostertag, Cornelia Bentley, Sophie Viaud
  • Anti-DLL4 antibodies and uses thereof
    Patent number: 9403904
    Abstract: Provided herein are anti-DLL4 antibodies and methods of using anti-DLL4 antibodies as therapeutic agents in diseases or disorders associated with DLL4.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: August 2, 2016
    Assignee: Fabrus, Inc.
    Inventors: Vaughn Smider, Helen Hongyuan Mao, Cornelia Bentley, Tyson Chase
  • ANTI-DLL4 ANTIBODIES AND USES THEREOF
    Publication number: 20110318339
    Abstract: Provided herein are anti-DLL4 antibodies and methods of using anti-DLL4 antibodies as therapeutic agents in diseases or disorders associated with DLL4.
    Type: Application
    Filed: November 4, 2009
    Publication date: December 29, 2011
    Inventors: Vaughn Smider, Helen Hongyuan Mao, Cornelia Bentley, Tyson Chase